Skip to main content
. 2018 May 15;3(5):5212–5221. doi: 10.1021/acsomega.8b00093

Figure 3.

Figure 3

Critical binding spots of PF-06380101, 4 to tubulin (panel A), and design of macrocyclic analogue 19 (panel B).